Position in CYTK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,615,628
+$363,470 QoQ
Shares Held
18,965
-0.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#230
of 477 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethic Inc. holds $40,271,041 across 35 Biotechnology names. CYTK ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,947 | $10,405,003 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,069 | $10,019,664 | |
| 3 | ARGX |
Argenx SE
|
4,376 | $4,059,921 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
31,679 | $2,511,827 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
18,965 | $1,615,628 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,172 | $1,556,927 | |
| 7 | MRNA |
Moderna, Inc.
|
15,694 | $1,099,050 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
9,345 | $885,438 |
All Filings in CYTK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,615,628 | 18,965 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,252,158 | 18,998 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,070,013 | 16,840 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $523,329 | 9,522 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||